about
Underutilization of information and knowledge in everyday medical practice: evaluation of a computer-based solution.Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases.Hantavirus and acute appendicitis--the diagnosis behind the diagnosis?Medical diagnosis as a linguistic gameComputerized history-taking as a tool to manage dyslipidemia.The spectrum of podoplanin expression in encapsulating peritoneal sclerosisLife-threatening hyperkalemia--an overlooked acute kidney injury with a serum creatinine rise in the 'normal' range.Histological criteria for encapsulating peritoneal sclerosis - a standardized approach.Encapsulating peritoneal sclerosis - an overview.Early stages of calciphylaxis: are skin biopsies the answer?Angiogenesis and cellularity in encapsulating peritoneal sclerosis.Should we recommend precautions during a hantavirus endemic?Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant.Urinary TIMP2⋅IGFBP7 for the prediction of platinum-induced acute renal injury.Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease[A 65-year-old man with history of claudication, palpable purpura and livedo reticularis].Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany.TKTL-1 expression in lung cancer.[Can dialysis be conducted too often?]Apoptosis of mesothelial cells caused by unphysiological characteristics of peritoneal dialysis fluids.[Is it useful to treat a severe renal insufficiency with thiazides?]Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.[Untreated homocystinuria in adulthood]Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.Tubulointerstitial nephritis in active tuberculosis - a single center experience.Influence of thyroid function on different kidney function tests.Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.Induction of metallothionein in mesothelial cells by zinc.Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients.The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients.Kardiorenales Syndrom[Salt appetite, cramps and palpitations in a 21-year old medical secretary]Drug interaction of herbal tea containing St. John's wort with cyclosporineStimulated IFNgamma and IL-10 secretion of blood mononuclear cells in patients on renal replacement therapies show different secretion patterns[How can factor X deficiency in nephropathy explained?]Cure of lifelong fatigue by calcium supplementationLost in the bedside game of gaps[Disturbances in volume and electrolytes with intestinal and kidney diseases]Osteoarthritis of the knee--clinical assessments and inflammatory markersUnchanged serum levels of advanced glycation endproducts in patients with liver disease
P50
Q33382545-92CCC521-7039-4B6C-9AFB-8BD2EC8D5EBFQ33388573-0FA4E081-27BA-4FBC-A8EA-D3349A132930Q33398751-2C07CA34-1D49-40CE-80E7-AAB2BF041009Q33892341-2C0CE3C0-EFBA-4E0E-A90C-FF243D4570A6Q34334836-C3D48C00-543E-477D-949B-84DF20500B1CQ34541907-72580C6C-1DC2-4331-8F99-F26FB3FEC289Q35957688-629F6F2E-BF9F-4AB1-91A6-61F93545E084Q36381259-1428C821-978D-4421-A955-8A337FAE82BFQ37860507-83E43AEC-2567-49FE-A980-17E1A5A55CA7Q39203290-A6F55522-149A-4F0B-8F63-F3FCDBB7736BQ40278273-951DF064-5825-4356-B137-AA2270303C92Q40332669-4DCC9237-84DD-499E-8479-9882E3E48E05Q40438531-6EF3B152-DDD2-4077-A841-57F5D66D0EEDQ40954510-4373A051-A725-428C-A20F-055F0BAB5396Q41134548-1EA362F6-F35E-46D6-A9DB-E074DF43942DQ43100051-5E4F4D84-19CC-4030-BC6D-92B44084F144Q43608010-CDD26C74-D08E-4FA2-BD5E-3F8D6F9EE157Q43658651-D58883D9-0F0E-4964-B60E-842EB71C0D24Q44337833-86F04095-093F-4C92-96A8-C0848ADF9EB2Q44655092-E0C5A4B3-4B36-438B-90A2-3D54BD550D6FQ44813316-13C0A65E-B2DB-42D2-9B27-D5E8F3DA5A8DQ46652570-2A0A4CBE-F459-41F6-A1B9-8B14DA7C000AQ46766602-E3A60AD5-5CF7-42DF-ADCC-E744E033FE76Q46823995-97CF13DF-CA3E-4F9B-A55A-C315129130FBQ47615167-CEF80872-DE45-483D-AEF7-5184D459AE10Q51539276-1CA4DFC9-52A8-49E9-93E9-F500FBB92F2EQ53377531-D195B4E9-8687-4C0F-8B31-7F0A491D6959Q53549703-2E83A02F-D65E-4835-98AD-9BA103808BB5Q53567709-AF593D0D-C957-4EC8-AA30-C9D0AD7AFE0AQ53651902-DDD74831-F0E0-4319-B478-B5CD7A0AAB55Q56686663-C962D2AB-1E78-446B-B7F3-F56F3CE2B94CQ64042101-108EBFAD-C247-4833-91A9-A527BEE79480Q73218902-6530E95A-8670-4330-BF42-45399771BE0CQ73223036-6A374187-BCF9-46AA-80FC-A5869DCAB6D5Q73368386-2A393041-B093-44B2-8B02-FE6AB05724C7Q74540922-F0D46FE4-6A59-49E2-912E-1E541CFAE684Q74811890-C50A233B-61E9-43B2-B492-E4B913D45507Q79157921-2690860D-45B4-43E6-A666-59F06315D4A0Q80067409-ECA62FE4-6BB7-45D3-A9F3-D2491DF9D25AQ80483015-A3504015-C95A-4007-B2BB-917BDF33C7CF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dominik Mark Alscher
@ast
Dominik Mark Alscher
@en
Dominik Mark Alscher
@es
Dominik Mark Alscher
@sl
type
label
Dominik Mark Alscher
@ast
Dominik Mark Alscher
@en
Dominik Mark Alscher
@es
Dominik Mark Alscher
@sl
altLabel
Dominik Alscher
@en
Mark Dominik Alscher
@en
prefLabel
Dominik Mark Alscher
@ast
Dominik Mark Alscher
@en
Dominik Mark Alscher
@es
Dominik Mark Alscher
@sl
P106
P1153
7003435221
P21
P2456
P31
P496
0000-0002-9658-1211